Technical Analysis for EDIT - Editas Medicine, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | -11.36% | |
| 20 DMA Resistance | Bearish | -11.04% | |
| Earnings Movers | Other | -11.04% | |
| Wide Bands | Range Expansion | -11.04% | |
| 20 DMA Resistance | Bearish | -11.20% | |
| Earnings Movers | Other | -11.20% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 16 hours ago |
| 1.5x Volume Pace | about 16 hours ago |
| 3x Volume Pace | about 16 hours ago |
| 5x Volume Pace | about 16 hours ago |
| Gapped Down (Full) | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/03/2024
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Enzymes Genetic Engineering Genome DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Genetics Enzymes Genetic Engineering Genome DNA CRISPR Genome Editing Cas9
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.9 |
| 52 Week Low | 4.91 |
| Average Volume | 2,050,344 |
| 200-Day Moving Average | 8.18 |
| 50-Day Moving Average | 7.11 |
| 20-Day Moving Average | 5.60 |
| 10-Day Moving Average | 5.43 |
| Average True Range | 0.36 |
| RSI (14) | 29.58 |
| ADX | 26.82 |
| +DI | 19.71 |
| -DI | 35.11 |
| Chandelier Exit (Long, 3 ATRs) | 5.95 |
| Chandelier Exit (Short, 3 ATRs) | 5.99 |
| Upper Bollinger Bands | 6.31 |
| Lower Bollinger Band | 4.89 |
| Percent B (%b) | 0.1 |
| BandWidth | 25.25 |
| MACD Line | -0.42 |
| MACD Signal Line | -0.50 |
| MACD Histogram | 0.0756 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.77 | ||||
| Resistance 3 (R3) | 5.81 | 5.61 | 5.65 | ||
| Resistance 2 (R2) | 5.61 | 5.42 | 5.59 | 5.61 | |
| Resistance 1 (R1) | 5.32 | 5.30 | 5.22 | 5.28 | 5.57 |
| Pivot Point | 5.12 | 5.12 | 5.06 | 5.10 | 5.12 |
| Support 1 (S1) | 4.83 | 4.93 | 4.73 | 4.79 | 4.50 |
| Support 2 (S2) | 4.63 | 4.81 | 4.61 | 4.46 | |
| Support 3 (S3) | 4.34 | 4.63 | 4.42 | ||
| Support 4 (S4) | 4.30 |
